Clinical pharmacist service promotes the improvement of medical quality

Hao Li, Wei Luan, Zhi-Chun Gu, Zhijie Xu, Jianrong Zhang, Shusen Sun

Frontiers Media SA

Health Public Health

Keywords: Clinical pharmacist,­Medical quality,­Medical Education

Novel methods and technologies for the evaluation of drug outcomes and policies

Zaheer-Ud-Din Babar, Dalia M. Dawoud, Blythe Adamson, Amr Makady, Grammati Sarri, Omneya Mohamed

Frontiers Media SA

As a leading Open Access publisher, Frontiers is committed to empowering not only scientists, but...

Science Pharmacology Drugs Outcomes Research and Policies

Keywords: #CollectionSeries,­health economics and outcomes research,­Economic Modelling,­Technologies,­drug,­policies

Effective methods to promote appropriate use of medicines

Tomoya Tachi, Yuki Kondo, Yen-Ming Huang

Frontiers Media SA

Science Pharmacology Drugs Outcomes Research and Policies

Keywords: Medicines,­Health maintenance,­Health Promotion,­Quality of Life,­Adverse drug effects,­Behavioral approaches,­Psychological approaches

Innovation in Ocular Pharmacology

Lucia Gozzo, Mario Damiano Toro, Vittorio Porciatti, Giovanni Luca Romano

Frontiers Media SA

Science Pharmacology Experimental Pharmacology and Drug Discovery

Keywords: Ocular pharmacology,­Pharmacological Targets,­Innovative treatment,­Rare Diseases,­Advanced therapeutic medicinal products

Evidence for Assessing Drug Safety and Drug Use in Older People - Volume II

Monique M. Elseviers, Luciane Cruz Lopes, Ria Benko, Martin Canis, Brian Godman, Fabiane Raquel Motter, Marcio Galvão Oliveira

Frontiers Media SA

Science Pharmacology Drugs Outcomes Research and Policies

Keywords: drug safety,­adverse drug reactions,­medication without harm,­older patients,­Pharmacovigilance

Opioids in the time of the COVID-19 pandemic: From cellular mechanisms to public health policy

Wendy Margaret Walwyn, Tim Hales, Kathryn Anne DeFea, Scott John

Frontiers Media SA

Health Public Health

Keywords: Opioid Overdose,­COVID-19,­public health policy,­pandemic,­cellular interactions

Pharmacoeconomics in the area of health technology assessment and outcomes research to prioritize resource use, innovation and investment

François R. Girardin, Isabelle Durand-Zaleski, Karen Cohen, Matthias Schwenkglenks

Frontiers Media SA

Science Pharmacology Drugs Outcomes Research and Policies

Keywords: Pharmacoeconomics,­cost-effectiveness analysis,­HTA (Health Technology Assessment),­quality-of-life,­Decision analytical model,­Willingness-to-pay threshold,­Value-based pricing,­Patient elicitation